Literature DB >> 4111979

Histocompatibility systems and disease states with particular reference to cancer.

R L Walford, G S Smith, H Waters.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4111979     DOI: 10.1111/j.1600-065x.1971.tb00464.x

Source DB:  PubMed          Journal:  Transplant Rev        ISSN: 0082-5948


× No keyword cloud information.
  12 in total

1.  [Lymphocyte stimulation of healthy probands with a "Hodgkin's HL-A type" (author's transl)].

Authors:  W Tittor; L Kredel; E Röck
Journal:  Klin Wochenschr       Date:  1976-10-15

Review 2.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

Review 3.  Associations between HL-A histocompatibility antigens and non-malignant diseases.

Authors:  L P Ryder; L S Nielson; A Svejgaard
Journal:  Humangenetik       Date:  1974

4.  HL-A antigens and malignant disease.

Authors:  S D Lawler
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  [HL-A antigens in retinoblastoma].

Authors:  P Schildberg; J Bertrams; W Höpping; E Kuwert
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1973

6.  HL-A-linked human immune-response genes.

Authors:  C E Buckley; F C Dorsey; R B Corley; W B Ralph; M A Woodbury; D B Amos
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

7.  Transformation of LMTK- cells with purified HLA class I genes. II. Serologic characterization of HLA-A3 and CW3 molecules.

Authors:  F A Lemonnier; P C Dubreuil; C Layet; M Malissen; D Bourel; P Mercier; B K Jakobsen; D H Caillol; A Svejgaard; F M Kourilsky; B R Jordan
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  How to escape immune surveillance?

Authors:  R M Zinkernagel
Journal:  Springer Semin Immunopathol       Date:  1982

9.  Survival and the HL-A system in acute lymphoblastic leukaemia.

Authors:  S D Lawler; P T Klouda; P G Smith; M M Till; R M Hardisty
Journal:  Br Med J       Date:  1974-03-23

10.  Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series.

Authors:  A Nunez-Roldan; I Szer; T Toguchi; J Cuttner; R Winchester
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.